These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10715510)

  • 1. Design and analysis of three treatment equivalence trials.
    Wiens BL; Iglewicz B
    Control Clin Trials; 2000 Apr; 21(2):127-37. PubMed ID: 10715510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On testing equivalence of three populations.
    Wiens BL; Iglewicz B
    J Biopharm Stat; 1999 Aug; 9(3):465-83. PubMed ID: 10473032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical vs clinical significance in product testing: can they be designed to satisfy equivalence?
    Kingman A
    J Public Health Dent; 1992; 52(6):353-60. PubMed ID: 1432923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalence testing with dental clinical trials.
    Burns DR; Elswick RK
    J Dent Res; 2001 Jun; 80(6):1513-7. PubMed ID: 11499504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample sizes for event rate equivalence trials using prior information.
    Gould AL
    Stat Med; 1993 Nov; 12(21):2009-23. PubMed ID: 8296111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between sample size and the definition of equivalence in non-inferiority drug studies.
    Millar JA; Burke V
    J Clin Pharm Ther; 2002 Oct; 27(5):329-33. PubMed ID: 12383133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A confirmatory strategy for therapeutic equivalence trials.
    Kieser M
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
    Tsong Y; Zhang JJ; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference of equivalence for the ratio of two normal means with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    J Biopharm Stat; 2014; 24(6):1264-79. PubMed ID: 25033269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian equivalency test for two independent binomial proportions.
    Kawasaki Y; Shimokawa A; Yamada H; Miyaoka E
    J Biopharm Stat; 2016; 26(4):781-9. PubMed ID: 26322683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some issues in the design and interpretation of 'negative' clinical studies.
    Makuch RW; Johnson MF
    Arch Intern Med; 1986 May; 146(5):986-9. PubMed ID: 3963987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Equivalence studies in cardiovascular diseases].
    Barbieri P; Marubini E
    Ital Heart J Suppl; 2004 Apr; 5(4):267-75. PubMed ID: 15346693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological standards for assessing therapeutic equivalence.
    Kirshner B
    J Clin Epidemiol; 1991; 44(8):839-49. PubMed ID: 1941037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.
    Lee ML; Lusher JM
    Stat Med; 1991 Mar; 10(3):433-41. PubMed ID: 1902967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.